Astellas Reports Fourth Death In Orphan Disease Gene Therapy Clinical Trial

The following is a news release from Astellas Pharma Inc. Read the release. Astellas Pharma Inc. reports that the ASPIRO clinical trial participant, who developed a serious adverse event as described on September 1, passed away on September 9. The cause of death is still pending. Astellas is gathering the relevant clinical information and incorporating […]